Cargando…
Novel Treatments Paradigms: Membranous Nephropathy
Primary membranous nephropathy (MN) is a kidney-specific autoimmune glomerular disease and the leading cause of nephrotic syndrome (NS) in White adults, usually caused by antiphospholipase A2 receptor (PLA2R) antibodies, although several new target antigens have been recently identified. It is chara...
Autores principales: | Rojas-Rivera, Jorge E., Ortiz, Alberto, Fervenza, Fernando C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014375/ https://www.ncbi.nlm.nih.gov/pubmed/36938069 http://dx.doi.org/10.1016/j.ekir.2022.12.011 |
Ejemplares similares
-
Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy
por: Rojas-Rivera, Jorge, et al.
Publicado: (2021) -
Future landscape for the management of membranous nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023) -
Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy
por: Zand, Ladan, et al.
Publicado: (2023) -
“Precision” Medicine in Membranous Nephropathy: Serology-Guided Therapy
por: Glassock, Richard J., et al.
Publicado: (2023) -
Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy
por: Cheungpasitporn, Wisit, et al.
Publicado: (2016)